Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Research Precise Targeted RNASeq Assays

Cellular Research has launched its Precise targeted RNAseq assays. The company also announced the commercial availability of application-focused panels for the Precise assays, including panels for oncology, induced pluripotent stem cells, and immunology. The assays use next-generation sequencing alongside the company's Molecular Indexing technology as an alternative to qPCR. The assays are available in 96- and 384-sample formats, enabling customers to sequence up to 4,608 samples in a single sequencing run.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.